Market Place
Sourcing Support
Avid Bio to be taken private by GHO, Ampersand in $1.1 bln deal
07 Nov 2024 //
REUTERS
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
12 Sep 2024 //
GLOBENEWSWIRE
Avid Bioservices Reports Q1 Financial Results
09 Sep 2024 //
GLOBENEWSWIRE
Avid Bioservices to Report Fiscal Q1 2025 Financial Results on Sept 9
03 Sep 2024 //
GLOBENEWSWIRE
Avid Bioservices Reports Q4 And FY 2024 Financial Results
02 Jul 2024 //
GLOBENEWSWIRE
Avid Bioservices To Report Q4 And FY2024 Results On July 2
01 Jul 2024 //
GLOBENEWSWIRE
Avid Bioservices Ecovadis Sustainability: Committed Badge Recognition Earned
23 May 2024 //
GLOBENEWSWIRE
Avid Bioservices to Participate at Upcoming Investor Conferences
06 May 2024 //
GLOBENEWSWIRE
Avid Reports Financial Results for Third Quarter Ended January 31, 2024
24 Apr 2024 //
GLOBENEWSWIRE
Avid Announces Receipt of Deficiency Notice Nasdaq Regarding Late Form 10-Q
20 Mar 2024 //
GLOBENEWSWIRE
Avid Bio Announces Certain Preliminary Financial Results for Third Quarter
06 Mar 2024 //
GLOBENEWSWIRE
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
06 Mar 2024 //
GLOBENEWSWIRE
Avid Bio Reports Financial Results for Second Quarter Ended October 31, 2023
07 Dec 2023 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for Second Quarter
30 Nov 2023 //
GLOBENEWSWIRE
Avid Bioservices Partners With CIRM to Provide CDMO Services for CGT Programs
08 Nov 2023 //
GLOBENEWSWIRE
Avid CGT plant becomes latest CDMO investment to come to fruition
20 Oct 2023 //
BIOPROCESS INTERNATIONAL
Avid Completes Construction of Gene Therapy Development Facility
17 Oct 2023 //
GLOBENEWSWIRE
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
26 Sep 2023 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023
07 Sep 2023 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for 1Q of Fiscal Year 2024
31 Aug 2023 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for 4Q and Fiscal Year Ended
21 Jun 2023 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year
14 Jun 2023 //
GLOBENEWSWIRE
Avid Bioservices to Participate in RBC Capital Markets Global Conference
10 May 2023 //
GLOBENEWSWIRE
Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion
04 Apr 2023 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for Q3 Ended January 31, 2023
13 Mar 2023 //
GLOBENEWSWIRE
Avid Bios to Report Financial Results for Third Quarter of Fiscal Year 2023
06 Mar 2023 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for 2Q Ended October 31 2022
06 Dec 2022 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year
29 Nov 2022 //
GLOBENEWSWIRE
Avid Bioservices Appoints People Vice President
16 Nov 2022 //
CONTRACTPHARMA
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
02 Nov 2022 //
PRESS RELEASE
TOMI to Install Custom Engineered Integrated iHP System in Avid Bioservices
10 Oct 2022 //
GLOBENEWSWIRE
Avid Bioservices to Participate in RBC Global CDMO Conference
27 Sep 2022 //
GLOBENEWSWIRE
Avid Bioservices to Participate in Morgan Stanley 20th Annual GHC
07 Sep 2022 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022
06 Sep 2022 //
GLOBENEWSWIRE
Avid Bioservices Names Pramthesh Patel as VP, Process Development
01 Sep 2022 //
CONTRACTPHARMA
Avid Bioservices to Report Financial Results for First Quarter of FY 2023
30 Aug 2022 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for Q4 and FY Ended April 30, 2022
29 Jun 2022 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year
22 Jun 2022 //
GLOBENEWSWIRE
Avid Bioservices and CRB Partner on Viral Vector Facility
17 Jun 2022 //
CONTRACTPHARMA
Avid Bio Announces Launch of Analytical and Process Development Suites
14 Jun 2022 //
GLOBENEWSWIRE
Avid Bioservices Announces Further Expansion of Process Development Capacity
13 Jun 2022 //
GLOBENEWSWIRE
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences
16 Mar 2022 //
GLOBENEWSWIRE
Avid Bio Reports Financial Results for Third Quarter Ended January 31, 2022
08 Mar 2022 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results for Q3 of Fiscal Year 2022
01 Mar 2022 //
GLOBENEWSWIRE
Avid Bioservices Opens Second Downstream Processing Suite
10 Jan 2022 //
CONTRACTPHARMA
Avid Reports Financial Results for Second Quarter Ended October 31, 2021
07 Dec 2021 //
GLOBENEWSWIRE
Avid Bioservices Appoints VP, Process Development, Viral Vector Technologies
05 Nov 2021 //
CONTRACTPHARMA
Avid Bioservices Expands CDMO Offerings into Cell and Gene Therapy Market
15 Oct 2021 //
CONTRACTPHARMA
Avid Announces Expansion into Viral Vector Development and Manufacturing
14 Oct 2021 //
GLOBENEWSWIRE
Avid Bioservices Appoints Chief Commercial Officer
11 Oct 2021 //
CONTRACTPHARMA
Avid Bioservices Reports First Quarter Financial Results & Recent Developments
08 Sep 2021 //
GLOBENEWSWIRE
Avid Bioservices Announces Appointment of Esther Alegria to Board of Directors
01 Jul 2021 //
GLOBENEWSWIRE
Avid Bioservices Reports Financial Results for Q4
29 Jun 2021 //
GLOBENEWSWIRE
Avid Bioservices to Report Financial Results For Quarter
22 Jun 2021 //
GLOBENEWSWIRE
Avid Bioservices to Manufacture Zynlonta for ADC Therapeutics
25 May 2021 //
CONTRACTPHARMA
Avid Bioservices to Serve as Commercial Manufacturer for ADC ’ ZYNLONTA™
25 May 2021 //
GLOBENEWSWIRE
Avid Bioservices, Announces Pricing of $125 Million Offering
09 Mar 2021 //
GLOBENEWSWIRE
Avid , with recent IPO and Covid-19 partnership in hand, launches 2nd phase
26 Feb 2021 //
ENDPTS
Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion
22 Feb 2021 //
CONTRACTPHARMA
Avid Bioservices Expands Biologics Manufacturing Capacity
22 Feb 2021 //
PHARMTECH
